For example, in AD, RNA-seq has highlighted altered expression of genes involved in amyloid-β metabolism (APP and BACE1), tau phosphorylation (MAPT), and neuroinflammation (TREM2 and CD33) [67]. This evidence concerns the gene BACE1 and Alzheimer disease.